1
Tamaki Kazuhiko, Yamaguchi Takahiro, Oda Kozo, Terasaka Naoki, Nakai Daisuke, Nakadai Masakazu: (Ja) 2以上の置換基を有するベンゼン化合物, (En) Benzene compound having 2 or more substituents. Daiichi Sankyo Company, Tamaki Kazuhiko, Yamaguchi Takahiro, Oda Kozo, Terasaka Naoki, Nakai Daisuke, Nakadai Masakazu, YAGUCHI Toshiaki, May 4, 2006: WO/2006/046593 (45 worldwide citation)

(EN) Disclosed is an excellent LXR modulator. Specifically disclosed is a compound represented by the general formula (I) below or the like. (I) [In the formula, R1 represents a -COR9 (wherein R9 represents an alkyl, optionally substituted alkoxy or optionally substituted amino); R2 represents an H, ...


2
Holmeide Anne Kristin, Hovland Ragnar, Brændvang Morten: Novel sulphur containing lipids for use as food supplement or as medicament. Pronova Biopharma Norge, Holmeide Anne Kristin, Hovland Ragnar, Brændvang Morten, Zacco Norway, January 21, 2010: WO/2010/008299 (7 worldwide citation)

The present invention relates to lipid compounds of the general formula (I): (I) wherein R1 is selected from a C10-C22 alkyl, a C10-C22 alkenyl having 1-6 double bonds, and a C10-C22 alkynyl having 1-6 triple bonds;R2 and R3 are the same or different and may be selected from a group of different sub ...


3
Melissa S Egbertson, Steve D Young, George D Hartman, Jacquelynn J Cook: Fibrinogen receptor antagonist prodrugs. Merck & Co, Richard S Parr, Melvin Winokur, November 9, 1999: US05981584 (3 worldwide citation)

Fibrinogen receptor antagonist prodrugs having the structure, for example, of ##STR1## more particularly, ##STR2##


4

5
Sugiyama Yuichiro: Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell. Toyota Jidosha Kabushiki Kaisha, Sugiyama Yuichiro, HIRAKI Yusuke, June 9, 2005: WO/2005/051899 (2 worldwide citation)

A novel polymer electrolyte is provided that enables a solid polymer electrolyte used in fuel cells, for example, to have sufficient proton conductivity even in a low-water-content state or a zero-water-content state by using a monomer compound represented by the general formula (1), and a graft cop ...


6

7
Sidduri Achytharao, Tilley Jefferson Wright: Phenylalaninol derivatives. Hoffmann La Roche, November 21, 2001: EP1154987-A1 (2 worldwide citation)

Compounds of formula (1) and the pharmaceutically acceptable salts and esters thereof wherein X and Y are as defined in the specification, are effective inhibitors of the binding of VCAM-1 to VLA-4 in vivo and are useful in treating inflammation in inflammatory diseases in which such binding acts to ...


8
Masatoshi Baba, Takuya Kakuta, Norio Tanaka, Eiichi Oya, Takashi Ikai, Tsutomu Nawamaki, Shigeomi Watanabe, Koichi Suzuki: Substituted benzoyl derivatives and selective herbicides. Nissan Chemical, Oblon Spivak McClelland Maier & Neustadt, March 10, 1992: US05094685 (2 worldwide citation)

A substituted benzoyl derivative having the formula: ##STR1## wherein X.sub.1 is C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.5 alkoxyalkyl, C.sub.1 -C.sub.4 haloalkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkoxy, cyano, nitro or halogen; X.sub.2 is --L--OR.sub.1 (wherein L is C.sub.1 -C.sub.4 al ...


9
Athanassios Tzikas, Paul Herzig: Bis(.beta.-hydroxyethylthio)-C.sub.1 -C.sub.4 -alkylamines. Ciba Geigy Corporation, George R Dohmann, Edward McC Roberts, January 14, 1992: US05081296 (2 worldwide citation)

This application relates to intermediates useful for the preparation of fiber-reactive dyes, said intermediates having the formulae ##STR1## in which B is a --(CH.sub.2).sub.n -- or --O--(CH.sub.2).sub.n -- radical, where n is 1 to 6; Q is selected from the group consisting of hydrogen, C.sub.1 -C.s ...


10
Isao Yoshida, Yuichi Mukai, Koji Ichikawa: Salt, photoresist composition and method for producing photoresist pattern. Sumitomo Chemical Company, Birch Stewart Kolasch & Birch, June 3, 2014: US08741544 (1 worldwide citation)

A photoresist composition containing a resin that is hardly soluble or insoluble, but which is soluble in an aqueous alkali solution by action of an acid, and a salt represented by formula (I): wherein Q1, Q2, L1, W1, W2, R1, R2, t1 and t2 are defined in the specification, and Z+ represents an organ ...